Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Thyroid Cancer, Papillary × Congresses as Topic × Clear all

Sponsor

Conditions

Uterine Cervical Neoplasms 3 Ganglioneuroblastoma 3 Vaginal Neoplasms 2 Neuroblastoma 2 Wilms Tumor 1 Testicular Neoplasms 1 Teratoma 1 Skin Neoplasms 1 Sarcoma, Ewing 1 Rhabdomyosarcoma 1 Recurrence 1 Pancreatic Neoplasms 1 Pancreatic Intraductal Neoplasms 1 Ovarian Germ Cell Cancer 1 Gliosarcoma 1 Glioma 1 Glioblastoma 1 Endodermal Sinus Tumor 1 Diffuse Intrinsic Pontine Glioma 1 Central Nervous System Neoplasms 1 Carcinoma, Renal Cell 1 Carcinoma, Endometrioid 1 Breast Neoplasms 1 Brain Neoplasms 1

Interventions

lenvatinib 3 Sunitinib 3 cabozantinib 2 AZD 6244 2 vandetanib 1 tremelimumab 1 tovorafenib 1 tanespimycin 1 selpercatinib 1 pralsetinib 1 pembrolizumab 1 durvalumab 1 dabrafenib 1 copanlisib 1 cediranib 1 alectinib 1 Vorinostat 1 Vemurafenib 1 Thyroidectomy 1 Thyroid (USP) 1 Sorafenib 1 Pharmacogenomic Testing 1 Lenalidomide 1 Iodine-131 1 Gefitinib 1 Ferrosoferric Oxide 1 Ethanol 1 Bortezomib 1 Administration, Cutaneous 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡